Eli Lilly signs $2.75 billion deal with AI drug developer Insilico Medicine
The Decoder
•
AI Business
US pharmaceutical giant Eli Lilly is betting big on AI-driven drug development, signing a $2.75B deal with Hong Kong-listed Insilico Medicine. The article Eli Lilly signs $2.